Tactile Medical to Release Fourth Quarter and Fiscal Year 2022 Financial Results on February 21, 2022
Tactile Systems Technology, Inc. (Nasdaq: TCMD) has announced that it will release its fourth quarter and fiscal year 2022 financial results on February 21, 2023, before market opening. The management will conduct a conference call at 8:00 AM ET on the same day, where they will discuss the quarter's performance. Participants can join via phone or through a live webcast available on the company's investor relations website. Tactile Medical specializes in at-home therapies for chronic conditions such as lymphedema and chronic venous insufficiency, aiming to enhance patient quality of life and improve healthcare accessibility.
- Expected release of fourth quarter and fiscal year 2022 financial results on February 21, indicating ongoing transparency.
- Focus on chronic conditions, potentially increasing market demand for Tactile Medical's therapies.
- None.
MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Tuesday, February 21st.
Management will host a conference call with a question and answer session at 8:00 a.m. Eastern Time on February 21st to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13736241. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13736241. The webcast will be archived at investors.tactilemedical.com.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
FAQ
When will Tactile Systems Technology release its fourth quarter 2022 financial results?
What time is the conference call for Tactile Systems Technology's financial results?
How can I access the webcast for Tactile Systems Technology's financial results?
What is Tactile Systems Technology focusing on in its business?
